» Articles » PMID: 39853884

Examining the Formalin Fixation Method for Maintaining High RNA Quality in Surgical Lung Specimens

Overview
Journal Thorac Cancer
Date 2025 Jan 24
PMID 39853884
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Multiplex genetic testing is recommended when treating nonsmall cell lung cancer. A certain percentage of test failures in RNA assays owing to poor surgical specimen quality have been documented, and fixation failure is a possible cause. At our institution, sheet-like fixation is performed to reduce fixation time. This study aimed to compare the quality of RNA from resected lung cancer specimens following different fixation methods.

Methods: Sheet-like fixation specimens (n = 15), conventional fixation specimens of the same resected lungs (n = 15), and other lung cancer specimens collected for conventional fixation and subjected to multiplex gene-panel testing (n = 22) were retrospectively examined. RNA was extracted from each specimen. RNA quality and quantity were compared, and the success rate of multiplex gene-panel testing was determined.

Results: The DV value was significantly higher in RNA extracted from sheet-like fixation samples (median 47.5%, interquartile range [IQR]:40.3-51.5) compared with RNA extracted from conventionally fixed samples or conventionally fixed samples of other patient specimens (median 21%, IQR:5.3-29.8 and median 16.3%, IQR:9.5-27.1, respectively). No significant difference was observed in nucleic acid concentration. The multiplex genetic analysis success rate was 95% with conventional methods (one failure); however, it was 100% with the sheet-like fixation method.

Conclusion: Sheet-like fixation preserved RNA extracted from lung cancer specimens, resulting in lesser degradation than with conventional fixation.

References
1.
Sakaguchi T, Iketani A, Furuhashi K, Nakamura Y, Suzuki Y, Ito K . A method to improve genetic analysis of lung cancer samples. Respirology. 2021; 26(9):887-890. PMC: 8457235. DOI: 10.1111/resp.14114. View

2.
Yatabe Y . Molecular pathology of non-small cell carcinoma. Histopathology. 2023; 84(1):50-66. DOI: 10.1111/his.15080. View

3.
Butter R, Halfwerk H, Radonic T, Lissenberg-Witte B, Thunnissen E . The impact of impaired tissue fixation in resected non-small-cell lung cancer on protein deterioration and DNA degradation. Lung Cancer. 2023; 178:108-115. DOI: 10.1016/j.lungcan.2023.02.007. View

4.
Riely G, Wood D, Ettinger D, Aisner D, Akerley W, Bauman J . Non-Small Cell Lung Cancer, Version 4.2024, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2024; 22(4):249-274. DOI: 10.6004/jnccn.2204.0023. View

5.
Kunimasa K, Matsumoto S, Nishino K, Nakamura H, Kuhara H, Tamiya M . Improvement strategies for successful next-generation sequencing analysis of lung cancer. Future Oncol. 2020; 16(22):1597-1606. DOI: 10.2217/fon-2020-0332. View